The oral bioavailability of a pleuromutilin antibiotic candidate is increased after co-administration with the CYP3A4 inhibitor ritonavir and the P-gp inhibitor zosuquidar formulated as amorphous solid dispersions

Emilie Fynbo Petersen, Charlotte Laurfelt Munch Rasmussen, Bala Krishna Prabhala, Christoffer Vogsen Heidtmann, Poul Nielsen, Carsten Uhd Nielsen*

*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

24 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The oral bioavailability of a pleuromutilin antibiotic candidate is increased after co-administration with the CYP3A4 inhibitor ritonavir and the P-gp inhibitor zosuquidar formulated as amorphous solid dispersions'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science